Australia TGA Updates Guidance on AI-Enabled Medical De…
On February 5, 2026, the Therapeutic Goods Administration (TGA) published updated guidance clarifying how artificial intelligence enabled so…
Read more
Vietnam Suspends Decree 46/2026 and Resolution 66.13 on…
On 5 February 2026, the Government of Vietnam announced Resolution No. 09/2026/NQ-CP, which temporarily suspends the application of Decree N…
Read more
Indonesia Ministry of Trade Introduces Import Ban on Su…
On January 2, 2026, Indonesia’s Database of Legislation published a new Ministry of Trade regulation that introduces a ban on the importat…
Read more
Indonesia BPOM Releases Draft Regulation on Ingredient …
On January 6, 2026, the Indonesian National Agency of Drug and Food Control (BPOM) published a draft regulation proposing updated labeling r…
Read more
Malaysia MOH Mandates New FarmaTag Hologram Label for P…
On December 17, 2025, the Ministry of Health Malaysia (MOH) announced a regulatory update introducing a new FarmaTag hologram security label…
Read more
HSA Singapore Issues Updated Guidance on Medical Device…
On 5 November 2025, the Health Sciences Authority (HSA) of Singapore released new guidance documents outlining regulatory requirements for m…
Read more
Singapore’s HSA Issues Updated Health Supplement Regu…
On 29 October 2025, the Health Sciences Authority (HSA) of Singapore published updated guidelines governing prohibited and restricted ingred…
Read more
Indonesia BPOM Revises Drug Registration Rules to Strea…
Published on August 19, 2025, by the Indonesian National Agency of Drug and Food Control (BPOM), Regulation No. 23 of 2025 introduces major…
Read more
RegASK sponsors Pharma Japan 2025
RegASK is proud to participate in Pharma Japan 2025, Japan’s premier executive conference for the pharmaceutical industry, bringing togeth…
Read more
RegASK sponsors DIA Singapore Annual Meeting 2025
Proud Silver Sponsor | Booth 7 RegASK is proud to be a Silver Sponsor of the DIA Singapore Annual Meeting 2025, one of Asia’s leading conf…
Read more